We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Long-Awaited SPL Mandate Will Boost Safety, Efficiency
FDA: Long-Awaited SPL Mandate Will Boost Safety, Efficiency
November 7, 2005
After some lengthy delays, the FDA this month will require drugmakers to adopt the structured product labeling (SPL) format for certain human drug labeling submissions, an agency official said.